Pacer Advisors’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146M | Sell |
509,737
-38,355
| -7% | -$11M | 0.36% | 62 |
|
|
2025
Q1 | $169M | Sell |
548,092
-49,542
| -8% | -$15.3M | 0.4% | 61 |
|
|
2024
Q4 | $211M | Buy |
597,634
+30,931
| +5% | +$10.9M | 0.45% | 61 |
|
|
2024
Q3 | $203M | Buy |
566,703
+4,869
| +0.9% | +$1.74M | 0.43% | 62 |
|
|
2024
Q2 | $179M | Buy |
561,834
+92,240
| +20% | +$29.4M | 0.41% | 64 |
|
|
2024
Q1 | $108M | Buy |
469,594
+156,795
| +50% | +$36M | 0.25% | 115 |
|
|
2023
Q4 | $68.8M | Buy |
312,799
+67,738
| +28% | +$14.9M | 0.19% | 132 |
|
|
2023
Q3 | $55.4M | Buy |
245,061
+31,633
| +15% | +$7.14M | 0.21% | 118 |
|
|
2023
Q2 | $47.1M | Buy |
213,428
+41,327
| +24% | +$9.12M | 0.19% | 114 |
|
|
2023
Q1 | $38.5M | Buy |
172,101
+161,777
| +1,567% | +$36.2M | 0.16% | 117 |
|
|
2022
Q4 | $2.87M | Sell |
10,324
-73,681
| -88% | -$20.5M | 0.01% | 512 |
|
|
2022
Q3 | $17.6M | Sell |
84,005
-18,308
| -18% | -$3.83M | 0.12% | 135 |
|
|
2022
Q2 | $24.1M | Buy |
102,313
+49,493
| +94% | +$11.7M | 0.18% | 106 |
|
|
2022
Q1 | $9.48M | Buy |
52,820
+48,176
| +1,037% | +$8.64M | 0.08% | 254 |
|
|
2021
Q4 | $1M | Sell |
4,644
-13,092
| -74% | -$2.83M | 0.01% | 1192 |
|
|
2021
Q3 | $3.27M | Buy |
17,736
+1,031
| +6% | +$190K | 0.04% | 551 |
|
|
2021
Q2 | $3M | Buy |
16,705
+3,306
| +25% | +$593K | 0.04% | 498 |
|
|
2021
Q1 | $2.24M | Sell |
13,399
-724
| -5% | -$121K | 0.04% | 481 |
|
|
2020
Q4 | $2.14M | Sell |
14,123
-7,107
| -33% | -$1.08M | 0.04% | 424 |
|
|
2020
Q3 | $2.14M | Buy |
21,230
+12,826
| +153% | +$1.3M | 0.05% | 392 |
|
|
2020
Q2 | $1.02M | Buy |
+8,404
| New | +$1.02M | 0.02% | 553 |
|
|
2020
Q1 | – | Sell |
-14,643
| Closed | -$1.29M | – | 1114 |
|
|
2019
Q4 | $1.29M | Sell |
14,643
-1,116
| -7% | -$98.3K | 0.06% | 467 |
|
|
2019
Q3 | $1.26M | Buy |
+15,759
| New | +$1.26M | 0.03% | 727 |
|
|
2019
Q1 | – | Sell |
-5,034
| Closed | -$548K | – | 768 |
|
|
2018
Q4 | $548K | Sell |
5,034
-16,953
| -77% | -$1.85M | 0.02% | 132 |
|
|
2018
Q3 | $2.81M | Buy |
21,987
+6,858
| +45% | +$877K | 0.11% | 194 |
|
|
2018
Q2 | $1.71M | Buy |
15,129
+2,454
| +19% | +$278K | 0.08% | 344 |
|
|
2018
Q1 | $1.42M | Buy |
12,675
+749
| +6% | +$84.1K | 0.08% | 320 |
|
|
2017
Q4 | $1.76M | Buy |
11,926
+4,738
| +66% | +$701K | 0.12% | 190 |
|
|
2017
Q3 | $842K | Buy |
7,188
+461
| +7% | +$54K | 0.07% | 379 |
|
|
2017
Q2 | $873K | Buy |
6,727
+1,026
| +18% | +$133K | 0.09% | 303 |
|
|
2017
Q1 | $772K | Buy |
5,701
+1,275
| +29% | +$173K | 0.09% | 281 |
|
|
2016
Q4 | $635K | Buy |
4,426
+145
| +3% | +$20.8K | 0.09% | 289 |
|
|
2016
Q3 | $506K | Buy |
4,281
+296
| +7% | +$35K | 0.08% | 362 |
|
|
2016
Q2 | $422K | Buy |
3,985
+3,307
| +488% | +$350K | 0.07% | 412 |
|
|
2016
Q1 | $76K | Buy |
678
+21
| +3% | +$2.35K | 0.02% | 703 |
|
|
2015
Q4 | $103K | Buy |
+657
| New | +$103K | 0.02% | 579 |
|